 This is a prospective, multi-center, randomized, crossover trial to evaluate the clinical effectiveness of red blood cells RBCs derived from Mirasol-treated whole blood WB versus conventional RBCs in transfusion dependent thalassemia patients. Throughout the clinical study, RBC transfusion volume and frequency will be determined by each subjects treating physician. 